Navigation Links
NIH awards Phylonix phase II SBIR to develop zebrafish models for eye diseases
Date:10/2/2007

Cambridge, MA October 2, 2007 Phylonix Pharmaceuticals, Inc. today announced that it has been awarded a $1,092,031 Phase II Small Business Innovation Grant (SBIR) from the National Eye Institute of the National Institutes of Health (NIH) to develop zebrafish eye disease models for drug screening. The grant for New Models for Eye Diseases will support the Phylonix program over a period of three years.

The eye is a highly conserved organ and the basic structure between human and zebrafish eyes is indistinguishable. In addition, numerous eye diseases have been modeled in zebrafish including choroidal neovascularization, similar to age-related macular degeneration (AMD) in humans; ocular scarring that occurs after surgery for glaucoma; retinopathy induced by diabetes and edema; and ocular ischemia caused by several pathologies.

The funding for this program will be used to further develop our novel, patent pending methods for modeling eye diseases and to identify potential drug candidates, commented Patricia McGrath, Phylonix President and Chief Executive Officer. Our preliminary data show good correlation between results in zebrafish and results in mammals and we are very pleased to receive this Phase II SBIR award from the National Eye Institute.

Phylonix is modeling a number of eye diseases in zebrafish including diabetic retinopathy and AMD, the two leading causes of blindness in adults in the industrialized world. Both conditions involve vascular abnormalities, proliferation and leakage of new blood vessels. Other eye diseases resulting in blindness that Phylonix is modeling in zebrafish include retinopathy of prematurity, a major cause of newborn blindness in premature infants maintained by oxygen supplementation during the postnatal period. This disease involves intense neovascularization of the retina and leads to retinal detachment. Another cause of blindness is corneal neovascularization, which often results from injury and infecti
'/>"/>

Contact: Edward O'Lear
ed.olear@phylonix.com
617-441-6700
Phylonix
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Aussie Nobel Prize Winners Receive Their Awards
2. Prestigious Gairdner Awards for medical research in 2006 Goes To Two Yale biologists
3. The President Gives Away National Disability Awards
4. Majority of Padma Awards Go to Doctors from Delhi
5. US, Indian Doctors Bag Thai Medical Awards
6. WHO Awards Prequalification Status to the First UAE Approved Vaccine
7. Bio-Rad Gets Life Science Industry Awards – 200
8. Michael J. Fox Foundation Awards $710,000 to Understanding of Parkinsons Disease Subtypes
9. Ontario Court Awards Compensation To Paralyzed Worker
10. Talwalkars Awards a Record $1 Million Order to Nautilus
11. NIH Awards Emory $3.6 Million for Schizophrenia Gene Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...ring drug tetrathiomolybdate (TM) has been shown i...on disease, a disease caused by an overload of cop...known. Very little, however, is known about how th...dy led by Northwestern University researchers now ...onal structure of TM bound to copper-loaded metall...
(Date:11/26/2009)...ill when on an emotional rollercoaster, study find... -- Call it the fear factor meets the jubilant spo... -- especially those who root for the winning team...ely contested match and victory was in doubt, prod...w on that this Thanksgiving weekend as you,re glue...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Center, ... , is one of a growing number of physicians who ar...ites to connect with individuals who are intereste...d obesity. Dr. Kim is utilizing Facebook to share ...practice with the community. , ...
(Date:11/26/2009)... Benton Communications announces a highly effe...r retailers struggling to make an economic recover... 2009 -- Flu fears is the type of challenge that c...om, according to Dr. David Benton, business growth...growth system – The Rfactor Intensive . &...
(Date:11/25/2009)...ov.25/PRNewswire-USNewswire/--Whenmostpeoplehearth...orcanalsogivepatientsthehelptheyneed.TMJstandsfort...dible)contacts/connectswithyourskull(temporalbone)...unctionarepainwithchewing,clickingorpoppingoftheja...nincluding:headaches,fatigue,sleepdisturbances,irr...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
..., SENSE OF URGENCY ABOUT HIV/AIDS EPIDEMIC ABROAD ...public supports maintaining (39%) or increasing (2...eveloping countries, while fewer than a quarter (2...s U.S. global health and development assistance. ...
... treatment at all, study shows , , THURSDA...e is essential for reducing the risk of heart dise...a matter of debate. , Now, two new analyses attemp...s (ARBs), probably because there aren,t enough stu...
...ay 7, 2009Approximately 6.3 million adultsor one f...itusare unaware they have the disease, and this un... billion in health care costs each year, according...he article is available free online at www.lieber...
...llinois at Chicago has received nearly $1 million ...lopment to study the benefits of green healthy hou...e American Recovery and Reinvestment Act of 2009. ... affordable, healthy housing. , At a time when th...
...Compounded Medication Program , , GLEN BURNIE, M...practice-to-home delivery veterinary pharmacy toda...y of more than 1,200 pet owners from across the U....lso indicated a very strong preference for orderin...
... Calif., May 7 PARI Pharma GmbH received an Orpha...n based on a positive recommendation by the EMEA f...tomized Investigational eFlow Nebulizer System. T...nhaled cyclosporine delivered via an eFlow Technol...
Other Medicine News:Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 2Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 3Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 4Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 5Health News:Americans Say Maintain or Increase Funding for Global Health and Development, But Take Care of Problems at Home First in the Recession 6Health News:All Blood Pressure Drugs Lower Risk of Heart Attack and Stroke 2Health News:All Blood Pressure Drugs Lower Risk of Heart Attack and Stroke 3Health News:UIC receives $1M HUD grant to study green healthy housing 2Health News:VetCentric Releases Findings of Pet Owner Survey 2Health News:PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward 2Health News:PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward 3Health News:PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward 4
(Date:11/25/2009)...,Fla., Nov.25/PRNewswire-FirstCall/--AmericanScie...ispleasedtoannouncethattheyhaveopenedaregionalmark.... ,, ASRhasbeenabletosecurealocationabroad,prov...ionofcurrentandfuturehealthandsafetyproductsforchi...ntlythecompanyhousesinventoryinthestateofOhiowhere...
(Date:11/25/2009)...TON,N.J.,Nov.25/PRNewswire-FirstCall/--Pharmasset,...mpanycommittedtodiscovering,developingandcommercia...ancialresultsforthefiscalyearendedSeptember30,2009...h,cashequivalentsandshortterminvestments. ,, P..., Phase2bTrial ,, InlateNovember2009,anind...
(Date:11/25/2009)...Pa.,Nov.25/PRNewswire/--BioTrendsResearchGroup,Inc... report,thefirstinamulti-phasesyndicatedmarketrese...h,sStelara,fromproductlaunchthroughthefirstsixmont...tativeinformationfrom75uniqueDermatologistsandqual...trialanduseofStelara,obstaclestouse,typicalpatient...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 1NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 2NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 3NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 4NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 5NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 6NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 7NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD 26 NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS 12377 8Religious devotion does not impact abortion decisions of young unwed women 47440 1Religious devotion does not impact abortion decisions of young unwed women 47440 2Back to normal 3A Surgery improves outcomes for spine patients 47438 1Back to normal 3A Surgery improves outcomes for spine patients 47438 2
...lowered blood pressure and signs of,heart muscle d...NN ARBOR, Mich., Oct. 29 Could eating,grapes help...? And could,grapes calm other factors that are als... A new University of Michigan Cardiovascular Cente... the October issue of the Journal of,Gerontology: ...
...2008 ICAAC/IDSA Joint Meeting, ROCKVILLE, Md., Oc...eutical company focused on commercializing,product...al, announces the,successful demonstration of syne...bitory concentration (MIC) resulting from in vitro...idate, SQ109, and Tibotec,s lead TB,drug candidate...
Other Medicine Technology:Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds 2Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds 3Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds 4Grapes May Aid a Bunch of Heart Risk Factors, U-M Animal Study Finds 5Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207 2
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: